SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-040329
Filing Date
2022-02-14
Accepted
2022-02-14 10:56:01
Documents
3
Group Members
COLUMBIA ACORN FUNDCOLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA WANGER ASSET MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d309774dsc13ga.htm SC 13G/A 79252
2 EX-99.I d309774dex99i.htm EX-99.I 1324
3 EX-99.II d309774dex99ii.htm EX-99.II 5584
  Complete submission text file 0001193125-22-040329.txt   88204
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 22627062
SIC: 2834 Pharmaceutical Preparations